Assessment of the REPLACE study composite endpoint in the PATENT study and association with long-term outcomes in riociguat-treated patients.

rev. colomb. neumol. [Internet]. 2020 Dec. 3 [cited 2024 Dec. 22];31(2). Disponible en: https://doi.org/10.30789/rcneumologia.v31.n2.2019.451